Furthermore, as in the development of vaccines, viral vectors are “armed” with genes that enhance the antitumor activity, the virus tropism or the immunoreactivity, to promote better tumor destruction, such as granulocyte-macrophage colony-stimulating factor (GM-CSF) or erythropoietin genes (enhanced virus; Table 3). The gene discussed is CSF2; the disease is neoplasm.